Year: 2012
Type: dissertation
Study design: Observational Study
Abstract: Background: Although myocardial fibrosis plays an important role in the progression of heart failure (HF;心不全), its prognostic impact still remains to be clarified.Methods and Results: I examined consecutive 172 patients with chronic HF, who underwent cardiac catheterization and endomyocardial biopsy from January 2001 to September 2008.I divided them into 2 groups; HF with preserved ejection fraction (HFPEF, left ventricular ejection fraction (LVEF;左室駆出率) ≥50%, n=81) and HF with reduced LVEF (HFREF, LVEF <50%, n=91).I calculated collagen volume fraction (CVF) in biopsy samples and examined its prognostic impact.Mean follow-up period in the HFPEF and the HFREF group was 41±33 [SD] and 41±26 months, respectively.Although the extent of CVF was comparable between the 2 groups (1.83±1.54% vs. 2.07±2.35%),CVF was significantly correlated with LVEDP in the HFREF group but not in the HFPEF group.When HF stage was adjusted, the long-term prognosis was comparable between the 2 groups.However, when the patients were divided into the 2 groups by the median CVF value, severe fibrosis was a significant predictor for all-cause death (P=0.014) and cardiac events (P=0.02) in the HFREF, but not in the HFPEF group.Conclusions: These results indicate that myocardial fibrosis evaluated with biopsy samples is a useful predictor for long-term survival, suggesting that it may be an important therapeutic target as well.
Author: 竜男 青木
Institution: Tohoku University
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: myocardial interstitial fibrosis, non-ischemic heart failure, collagen volume fraction, endomyocardial biopsy, heart failure with preserved ejection fraction, heart failure with reduced ejection fraction, left ventricular end-diastolic pressure, all-cause mortality, prognosis, long-term survival
Open Access status: green
OpenAlex ID: W2291212315
